The ground seems to be ready for a defense for humans against the coronavirus pandemic. Moderna Inc.’s vaccine candidate protected 16 monkeys in a trial. Its result in 30,000 humans is awaited, reported livemint.
Two injections of the vaccine protected against heavy exposure to the virus at two different levels of dosage, Moderna said in findings published on Tuesday in the New England Journal of Medicine, reported livemint.
The results on primates
The results, if they hold up in humans, suggest that the vaccine may be able to protect against Covid-19 in both the upper and lower airways, reported livemint quoting the study.
Phase 3 trial to determine the safety and efficacy of the vaccine will begin producing data in November or December. The U.S. government is providing $955 million to help fund the vaccine’s development.
Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, which is $11 more than another vaccine from Pfizer Inc and BioNTech, livemint quoted Financial Times as reporting on Tuesday, citing unnamed sources.
New Delhi: Assembly elections in Jammu & Kashmir got underway on Wednesday on a peaceful…
Bhubaneswar: As several areas of Odisha faced a flood situation following heavy downpour triggered by…
Bhubaneswar: Pumping iron daily to become a weightlifter is no doubt a rugged and hazardous…
Bhubaneswar: The Odisha government on Wednesday issued fresh guidelines to ensure safety of doctors, para-medical…
New Delhi: A day after thousands of pagers belonging to Hezbollah exploded throughout Lebanon, hand-held…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Wednesday welcomed the approval given by the…
Bhubaneswar: In view of Monkeypox outbreak and the World Health Organisation declaring a public health…
Mumbai: Squadron Leader Mohana Singh is flying high by breaking barriers. She will become India’s…